Sanzone Virginia Ruth 4

Accession 0001669639-24-000001

CIK 0000883984other

View on SEC.gov Company Profile

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 4:24 PM ET

Size

23.0 KB

Accession

0001669639-24-000001

Insider Transaction Report

Form 4

Period: 2024-03-07

ICU MEDICAL INC/DEICUI

Sanzone Virginia Ruth

VP, General Counsel

Transactions

Tax Payment
Common Stock
2024-03-07$105.39/sh−3,529$371,921→ 8,071 total
Exercise/Conversion
Common Stock
2024-03-07+1,073→ 5,751 total
Tax Payment
Common Stock
2024-03-07$105.39/sh−587$61,864→ 5,164 total
Sale
Common Stock
2024-03-08$104.57/sh−3,300$345,088→ 4,771 total
Exercise/Conversion
Common Stock
2024-03-07+6,436→ 11,600 total
Exercise/Conversion
Common Stock
2024-03-08+2,273→ 7,044 total
Tax Payment
Common Stock
2024-03-08$104.52/sh−1,246$130,232→ 5,798 total
Award
Common Stock
2024-03-08+9,568→ 9,568 total
→ Common Stock (9,568 underlying)
Exercise/Conversion
Performance Shares
2024-03-07−6,436→ 0 total
Exercise: $0.00Exp: 2024-03-07→ Common Stock (6,436 underlying)
Exercise/Conversion
Common Stock
2024-03-07−1,073→ 1,073 total
Exercise: $0.00From: 2023-03-07Exp: 2025-03-07→ Common Stock (1,073 underlying)
Exercise/Conversion
Performance Shares
2024-03-08−2,273→ 0 total
Exercise: $0.00From: 2023-03-08Exp: 2024-03-08→ Common Stock (2,273 underlying)

Footnotes (9)

[F1]These securities are Restricted Stock Units.
[F2]These Securities are Performance-based Restricted Stock Units (PRSU).
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.54 to $104.84, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F4]There is neither a purchase price nor an exercise price for the Restricted Stock Units.
[F5]One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
[F6]These are restricted stock units that fully vest 3 years from the grant date.
[F7]There is neither a purchase price nor an exercise price for the PRSUs.
[F8]These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant.
[F9]These PRSUs were granted on March 8, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

ICU MEDICAL INC/DE

CIK 0000883984

→

Entity typeother

Related Parties

filerCIK 0001669639

Filing Metadata

Form type: 4
Filed: Mar 10, 8:00 PM ET
Accepted: Mar 11, 4:24 PM ET
Size: 23.0 KB

View on SEC.gov